In the present study, we found that TGFBR1 gene silencing inhibited cardiac hypertrophy in HFpEF mice by suppressing the TAK1–P38/MAPK–JNK1/2 signaling pathway, and similar results were observed in vitro. This evidence concerns the gene TGFBR1 and cardiac hypertrophy.